BD FACSDiscover™ A8 Cell Analyzer to Enable Investigation of 30+ Cellular Characteristics to Capture Key Biological Insights and Support Planned 1,000-Person ImmuneBD FACSDiscover™ A8 Cell Analyzer to Enable Investigation of 30+ Cellular Characteristics to Capture Key Biological Insights and Support Planned 1,000-Person Immune

BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry

BD FACSDiscover™ A8 Cell Analyzer to Enable Investigation of 30+ Cellular Characteristics to Capture Key Biological Insights and Support Planned 1,000-Person Immune Profiling Study

FRANKLIN LAKES, N.J., Dec. 18, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania, to advance research in deep human immune profiling and support the development of immune-mediated therapies.

The collaboration includes developing and validating a high-parameter flow cytometry panel that can capture key functional pathways in whole blood, including phosphorylation markers, which provide powerful insight into how single cells respond to drugs or disease states. The panel will support a planned 1,000-patient immune profiling study, in partnership with the Penn Colton Center for Autoimmunity, expected to start this summer. The project will leverage the BD FACSDiscover™ A8 Cell Analyzer, BD Rhapsody™ System, BD reagents, software and informatics, with BD teams managing reagents, instrumentation, and spectral data algorithms, and I3H teams serving as scientific and clinical leads. The team intends to publish a peer-reviewed manuscript describing the results of the study.

“This project demonstrates the power of collaboration between academia and industry,” said Dr. E. John Wherry, PhD, the Richard and Barbara Schiffrin President’s Distinguished Professor, director of the Institute for Immunology and Immune Health at the University of Pennsylvania, and the director of the Colton Consortium for Autoimmunity. “We are bringing together cross-functional experts to transform human immune profiling for maximum impact, enabling deeper insights from our immune cells that could accelerate development of precise medical treatments.”

The collaboration reflects a shared vision of unlocking the power of the human immune system to advance science and health. It is made possible by the BD FACSDiscover™ A8 Cell Analyzer, which is the first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies, and the new BD Horizon™ Chroma solution for dried high-parameter panels. The project supports the commitment of both organizations to contribute to the research community through collaboration and knowledge sharing.

“High-parameter single-cell studies of this kind, once considered infeasible, are increasingly becoming central to better understanding the human immune system,” said Steve Conly, worldwide president of BD Biosciences. “Our ecosystem of industry-leading BD flow cytometers, single-cell systems, reagents, software and informatics, provide a critical missing puzzle piece that can support the important work of organizations like I3H to translate and deliver immunological insights into quantitative, actionable information for discovery and clinical care teams around the world.”

More information is available at bdbiosciences.com.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. 

Contacts:

Media:

Investors:

Fallon McLoughlin

Adam Reiffe

Director, Public Relations

VP, Investor Relations

201.258.0361

201.847.6927

fallon.mcloughlin@bd.com

adam.reiffe@bd.com

Media for Penn Medicine:

Eric Horvath

Associate News Director

Penn Medicine

215-821-4289

Eric.horvath@pennmedicine.upenn.edu

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-and-penn-institute-for-immunology-and-immune-health-collaborate-to-advance-immunotherapy-through-flow-cytometry-302645260.html

SOURCE BD (Becton, Dickinson and Company)

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

JPMorgan Reveals Startling Investor Shift To Precious Metals

JPMorgan Reveals Startling Investor Shift To Precious Metals

The post JPMorgan Reveals Startling Investor Shift To Precious Metals appeared on BitcoinEthereumNews.com. Bitcoin Futures Oversold: JPMorgan Reveals Startling
Share
BitcoinEthereumNews2026/01/31 06:26
Pibble AI platform: Revolutionary AION Completes POSCO International POC with Stunning Success

Pibble AI platform: Revolutionary AION Completes POSCO International POC with Stunning Success

BitcoinWorld Pibble AI platform: Revolutionary AION Completes POSCO International POC with Stunning Success The world of trade is constantly evolving, with businesses seeking innovative solutions to enhance efficiency and accuracy. In this dynamic landscape, the Pibble AI platform AION has emerged as a groundbreaking force, recently completing a significant Proof-of-Concept (POC) with global trading giant POSCO International. This achievement signals a major leap forward in how artificial intelligence and blockchain technology can revolutionize B2B operations. What is the Pibble AI Platform AION and Its Recent Breakthrough? AION is an advanced AI trade solution developed by Caramel Bay, the innovative operator behind the Pibble (PIB) blockchain project. Its core mission is to streamline complex trade processes, which traditionally involve extensive manual labor and time-consuming documentation. The recent POC with POSCO International was a pivotal moment for the Pibble AI platform. It served as a real-world test, demonstrating AION’s capabilities in a demanding corporate environment. This collaboration showcased how cutting-edge technology can address practical business challenges, particularly in international trade. The results were truly impressive. The platform proved its ability to drastically cut down the time required for specific tasks. What once took hours of meticulous work can now be completed in mere minutes. Moreover, AION achieved an astonishing document accuracy rate of over 95%, setting a new benchmark for efficiency and reliability in trade operations. This high level of precision is crucial for reducing errors and associated costs in large-scale international transactions. Revolutionizing Trade: How the Pibble AI Platform Delivers Speed and Accuracy Imagine reducing hours of work to just minutes while simultaneously boosting accuracy. This isn’t a futuristic fantasy; it’s the tangible reality delivered by the Pibble AI platform AION. The successful POC with POSCO International vividly illustrates the transformative power of this technology. Key benefits highlighted during the POC include: Unprecedented Speed: Tasks that typically consumed significant human resources and time were executed with remarkable swiftness. This acceleration translates directly into faster transaction cycles and improved operational flow for businesses. Superior Accuracy: Achieving over 95% document accuracy is a monumental feat in an industry where even minor errors can lead to substantial financial losses and logistical nightmares. AION’s precision minimizes risks and enhances trust in digital documentation. Operational Efficiency: By automating and optimizing critical trade processes, the Pibble AI platform frees up human capital. Employees can then focus on more strategic tasks that require human intuition and decision-making, rather than repetitive data entry or verification. This efficiency isn’t just about saving time; it’s about creating a more robust, less error-prone system that can handle the complexities of global trade with ease. The implications for businesses involved in import/export, logistics, and supply chain management are profound. Beyond the POC: Pibble’s Vision for AI and Blockchain Integration The successful POC with POSCO International is just one step in Pibble’s ambitious journey. The company is dedicated to building validated platforms that leverage both blockchain and AI technologies, catering to a broad spectrum of needs. Pibble’s strategic focus encompasses: B2C Social Platforms: Developing consumer-facing applications that integrate blockchain for enhanced data security, content ownership, and user engagement. B2B Business Solutions: Expanding on successes like AION to offer robust, scalable solutions for various industries, addressing critical business challenges with AI-driven insights and blockchain transparency. The synergy between AI and blockchain is powerful. AI provides the intelligence for automation and optimization, while blockchain offers immutable records, transparency, and enhanced security. Together, they create a formidable foundation for future digital ecosystems. As the digital transformation accelerates, platforms like the Pibble AI platform are poised to play a crucial role in shaping how businesses operate and interact globally. Their commitment to innovation and practical application demonstrates a clear path forward for enterprise-grade blockchain and AI solutions. In conclusion, the successful POC of Pibble’s AION with POSCO International marks a significant milestone in the adoption of AI and blockchain in enterprise solutions. By dramatically reducing task times and achieving exceptional accuracy, the Pibble AI platform has demonstrated its potential to redefine efficiency in global trade. This achievement not only validates Caramel Bay’s vision but also paves the way for a future where intelligent, secure, and highly efficient digital platforms drive business success. It’s an exciting glimpse into the future of B2B innovation. Frequently Asked Questions (FAQs) Q1: What is the Pibble AI platform AION? AION is an advanced AI trade solution developed by Caramel Bay, the company behind the Pibble blockchain project. It’s designed to automate and optimize complex trade processes, reducing manual effort and improving accuracy. Q2: What was the significance of the POC with POSCO International? The Proof-of-Concept (POC) with POSCO International demonstrated AION’s real-world effectiveness. It showed that the Pibble AI platform could reduce tasks from hours to minutes and achieve over 95% document accuracy in a demanding corporate environment, validating its capabilities. Q3: How does AION achieve such high accuracy and speed? AION leverages sophisticated artificial intelligence algorithms to process and verify trade documentation. This AI-driven approach allows for rapid analysis and identification of discrepancies, leading to significant time savings and a dramatic reduction in human error. Q4: What is Pibble’s broader vision beyond B2B solutions? Pibble is committed to integrating blockchain and AI across various platforms. While AION focuses on B2B solutions, Pibble also develops B2C social platforms, aiming to enhance user experience, data security, and content ownership through these advanced technologies. Q5: Why is the combination of AI and blockchain important for trade? AI provides the intelligence for automation and optimization, making processes faster and more accurate. Blockchain, on the other hand, offers immutable records, transparency, and enhanced security, ensuring that trade data is reliable and tamper-proof. Together, they create a powerful, trustworthy, and efficient trade ecosystem. If you found this insight into Pibble’s groundbreaking achievements inspiring, consider sharing this article with your network! Help us spread the word about how AI and blockchain are transforming global trade. Your shares on social media platforms like X (Twitter), LinkedIn, and Facebook can help more people discover the future of business solutions. To learn more about the latest crypto market trends, explore our article on key developments shaping AI in crypto institutional adoption. This post Pibble AI platform: Revolutionary AION Completes POSCO International POC with Stunning Success first appeared on BitcoinWorld.
Share
Coinstats2025/09/18 19:45
Zcash Price Prediction: $16 Million Bets on a Crash – Is ZEC About to Get Wrecked?

Zcash Price Prediction: $16 Million Bets on a Crash – Is ZEC About to Get Wrecked?

Technical structure is weakening, momentum is stalling, and derivatives positioning shows clear bearishness – but are Zcash price predictions really damned?
Share
Coinstats2026/01/31 05:48